3D microtumors in vitro supported by perfused vascular networks
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors and stromal cells (endothelial cells) coexisted in these microvessels networks for up to 24 days.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumors grew vigorously in the 3D extracellular matrix, depending for survival entirely on nutrient delivery through living, fully functional, and leak-free vasculature.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remarkably, HCT116-cells growing in the vascularized microfluidic tumors exhibited chemoresistance to oxaliplatin that was one order higher than that shown by cells cultured in a 2D monolayer.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Specifically, this model allows for the creation of “vascularized micro-tumors” (VMTs), whereby the coculture of endothelial colony-forming cell-derived ECs, normal human lung fibroblasts and cancer cells under dynamic flow conditions enables the de novo formation of perfusable microvascular networks that surround the micro-tumors, supplying nutrients and therapeutics just as tumor-associated”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Sobrino et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The authors recreated, in a geometrically simple device (Figure 7e-i), a fully perfusable and complex vasculature network and was able to demonstrate the feasibility of culturing tumor spheroids for extended time periods.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cited by
Items 201–300 of 388
Lin, D. S. Y., Rajasekar, S., Marway, M. K., & Zhang, B. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00236 · Cited by 32
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Breast Cancer Research · doi:10.1186/s13058-023-01760-y · Cited by 24
“The VMT is a microphysiologic in vitro cancer model that we have validated for disease modeling, drug screening and personalized medicine applications for solid tumors [13–17].”
MethodSelf-citationLee, J., Park, D., Seo, Y., Chung, J. J., Jung, Y., & Kim, S. H. (2020) · Advanced Materials · doi:10.1002/adma.202002096 · Cited by 24
Tissue Engineering of the Microvasculature
Tien, J. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180037 · Cited by 32
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies
Campisi, M., Shelton, S. E., Chen, M., Kamm, R. D., Barbie, D. A., & Knelson, E. H. (2022) · Cancers · doi:10.3390/cancers14153561 · Cited by 25
“The ability to generate perfusable microvascular networks in vitro has, however, allowed the visualization of physiologically relevant events in realtime, such as transendothelial extravasation of tumor cells [103–105], as well as the modeling of vascularized microtumors [87].”
BackgroundSánchez-Salazar, M. G., Oliver, R. C.-L., Ramos-Meizoso, S., Jerezano-Flores, V. S., Gallegos-Martínez, S., Bolívar‐Monsalve, E. J., Ceballos‐González, C. F., Santiago, G. T., & Álvarez, M. M. (2023) · Bioengineering · doi:10.3390/bioengineering10050554 · Cited by 26
“elements, such as the 3D architecture of real tumors [9] and the possibility of recreating the dynamics that occur in the tumor niche (i.”
BackgroundVascularized Biomaterials to Study Cancer Metastasis
Bittner, K. R., Jiménez, J. M., & Peyton, S. R. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901459 · Cited by 27
The Impact of Oxygen Availability and Multilineage Communication on Organoid Maturation
Wörsdörfer, P., & Ergün, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8195 · Cited by 24
“This indicates that connecting prevascularized organoids to millifluidic chips (50) or microfluidic systems (120) could greatly enhance vascular network formation and maybe even more important maturation of the vessel wall initiated by flow-induced shear stress that is sensed by the cells of the…”
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
“Other teams had also developed similar models using colorectal cancer cells and EC lines [34, 38, 47].”
BackgroundResultInfluentialMartier, A. T., Chen, Z., Schaps, H., Mondrinos, M. J., & Fang, J. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1425618 · Cited by 25
“…system (Xiao et al., 2017), the pancreatic islet (Bender et al., 2024), the blood-brain barrier (Phan et al., 2017; Campisi et al., 2018), and cancer growth and metastasis (Jeon et al., 2015; Sobrino et al., 2016; Chen et al., 2017; Hachey et al., 2021; Hachey et al., 2024) among many others.”
BackgroundDesign considerations for engineering 3D models to study vascular pathologies in vitro
Lust, S. T., Shanahan, C. M., Shipley, R. J., Lamata, P., & Gentleman, E. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.031 · Cited by 26
Transendothelial migration induces differential migration dynamics of leukocytes in tissue matrix
van Steen, A. C. I., Kempers, L., Schoppmeyer, R., Blokker, M., Beebe, D. J., Nolte, M. A., & van Buul, J. D. (2021) · Journal of Cell Science · doi:10.1242/jcs.258690 · Cited by 24
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer
Jahid, S., Ortega, J. A., Vuong, L. M., Acquistapace, I. M., Hachey, S. J., Flesher, J. L., La Serra, M. A., Brindani, N., La Sala, G., Manigrasso, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110641 · Cited by 21
“Vascularized Microtumor Assay Methods for microfluidic device fabrication and establishing VMTs have been described previously (Sobrino 2016).”
MethodSelf-citationMimicking and surpassing the xenograft model with cancer-on-chip technology
Komen, J., van Neerven, S. M., van den Berg, A., Vermeulen, L., & van der Meer, A. D. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103303 · Cited by 24
Shuchat, S., Yossifon, G., & Huleihel, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105402 · Cited by 25
“anastomosed to the main channel, allowing the perfusion of the cell culture via the vasculature [43].”
BackgroundBiomaterials to promote vascularization in tissue engineering organs and ischemic fibrotic diseases
Zhao, W., Zhu, J., Hang, J., & Zeng, W. (2022) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.16 · Cited by 25
Rivera-Soto, R., & Damania, B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01544 · Cited by 23
“One such tool consists of the “organ-on-chip” technology that allows for the study of vascularized microtumors (VMT) using real-time fluorescence microscopy (Sobrino et al., 2016).”
MethodMicrophysiological model of renal cell carcinoma to inform anti-angiogenic therapy
Virumbrales-Muñoz, M., Ayuso, J. M., Loken, J. R., Denecke, K. M., Rehman, S., Skala, M. C., Abel, E. J., & Beebe, D. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121454 · Cited by 20
Recent Advances and Future Perspectives in Vascular Organoids and Vessel-on-Chip
Cheruku, G. R., Wilson, C. V., Raviendran, S., & Xiao, Q. (2024) · Organoids · doi:10.3390/organoids3030014 · Cited by 25
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
Iyer, K. K., van Erp, N. P., Tauriello, D. V. F., Verheul, H. M. W., & Poel, D. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102466 · Cited by 20
Microphysiological systems to study colorectal cancer: state-of-the-art
Ramos, P., Carvalho, M. R., Chen, W., Yan, L., Zhang, C., He, Y., Reis, R. L., & Oliveira, J. M. (2023) · Biofabrication · doi:10.1088/1758-5090/acc279 · Cited by 24
“A research study by Sobrino et al [61] has developed a tumouron-a-chip loaded with HCT-116 cells and human endothelial colony forming cell-derived ECs.”
MethodCarra, S., Gaudenzi, G., Dicitore, A., Saronni, D., Cantone, M. C., Plebani, A., Ghilardi, A., Borghi, M. O., Hofland, L. J., Persani, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063031 · Cited by 20
“Interestingly, CAB had more effective results than VAN, probably due to its activity against TIE-2, as well as to VEGFR-2 [47].”
BackgroundInfluentialWang, X., Zhao, H., Luo, X., Yang, C., Shi, C., Wang, Y., Bai, J., Shao, Z., & Shang, Z. (2024) · Oncogene · doi:10.1038/s41388-024-03112-2 · Cited by 23
“( Created with BioRender.com).”
Self-citationEngineered Vasculature for Cancer Research and Regenerative Medicine
Nguyen, H. T., Peirsman, A., Tirpáková, Z., Mandal, K., Vanlauwe, F., Maity, S., Kawakita, S., Khorsandi, D., Herculano, R. D., Umemura, C., et al. (2023) · Micromachines · doi:10.3390/mi14050978 · Cited by 19
Wong, A. D., Russell, L. M., Katt, M. E., & Searson, P. C. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00877 · Cited by 22
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 22
Self-citationVascularizing organoids-on-chip for perfused and personalized models
Menzani, B., Gea, P. D., Gidrol, X., & Tubbs, E. (2026) · Lab on a Chip · doi:10.1039/d5lc00890e · Cited by 23
Lung on a Chip Development from Off-Stoichiometry Thiol–Ene Polymer
Rimša, R., Galvanovskis, A., Plūme, J., Rūmnieks, F., Grindulis, K., Paidere, G., Erentraute, S., Mozoļevskis, G., & Ābols, A. (2021) · Micromachines · doi:10.3390/mi12050546 · Cited by 19
Bourn, M. D., Mohajerani, S. Z., Mavria, G., Ingram, N., Coletta, P. L., Evans, S. D., & Peyman, S. A. (2023) · Lab on a Chip · doi:10.1039/d2lc00963c · Cited by 20
Engineering high throughput screening platforms of cervical cancer
Cadena, I., Buchanan, M. R., Harris, C. G., Jenne, M., Rochefort, W. E., Nelson, D., & Fogg, K. C. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37522 · Cited by 16
You-on-a-chip’ for precision medicine
Low, L. A., & Tagle, D. A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1456333 · Cited by 18
“Tissue chips have been developed that model a wide variety of organs – including the heart [23,24], liver [25–27], gut [28,29], brain [30–33], muscle [34], and vasculature [35], among many others [5,13].”
BackgroundAmemiya, T., Hata, N., Mizoguchi, M., Yokokawa, R., Kawamura, Y., Hatae, R., Sangatsuda, Y., Kuga, D., Fujioka, Y., Takigawa, K., et al. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06061-7 · Cited by 20
Vascularized organoid-on-a-chip for centimeter-scale organoid cultivation
Gong, X. Y., Chen, Y., Peng, J., Ding, X. L., Yang, H., Wang, A. G., Dzakah, E. E., & Zhao, B. T. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2400424 · Cited by 23
“…obstacles in creating organ systems with capillary-like structures that accurately mimic the functionality of real microvascular net ‐ works because of 3D printing limitations in terms of resolu ‐ tion, material properties, and the ability to print complex geometries at small scales [7, 14].”
From simplicity to complexity in current melanoma models
Michielon, E., de Gruijl, T. D., & Gibbs, S. (2022) · Experimental Dermatology · doi:10.1111/exd.14675 · Cited by 19
Continuously perfusable, customisable, and matrix-free vasculature on a chip platform
Chesnais, F., Joel, J., Hue, J., Shakib, S., Silvio, L. D., Grigoriadis, A. E., Coward, T. J., & Veschini, L. (2023) · Lab on a Chip · doi:10.1039/d2lc00930g · Cited by 18
Development of Organs-on-Chips and Their Impact on Precision Medicine and Advanced System Simulation
Luo, Y., Li, X., Zhao, Y., Zhong, W., Xing, M. M. Q., & Lyu, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082094 · Cited by 18
Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
Farooqi, M. A., Kang, C.-U., & Choi, K. H. (2023) · ACS Omega · doi:10.1021/acsomega.3c03155 · Cited by 20
Akolawala, Q., Keuning, F., Rovituso, M., van Burik, W., van der Wal, E., Versteeg, H. H., Rondon, A. M. R., & Accardo, A. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302988 · Cited by 22
Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research
Low, L. A., & Tagle, D. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_23 · Cited by 19
Effect of Integrin Binding Peptide on Vascularization of Scaffold-Free Microtissue Spheroids
Çevik, Z. B. Y., Pulat, G., & Karaman, O. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00281-5 · Cited by 19
Chen, L., Kenkel, S., Hsieh, P.-H., Gryka, M. C., & Bhargava, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12158 · Cited by 20
Organotypic stromal cells impact endothelial cell transcriptome in 3D microvessel networks
Curtis, M. B., Kelly, N., Hughes, C. C. W., & George, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-24013-y · Cited by 18
Self-citationDurbin, K. R., Nottoli, M. S., & Jenkins, G. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-57789-y · Cited by 17
Harnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer
Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 16
Lung-on-chip microdevices to foster pulmonary drug discovery
Sisodia, Y., Shah, K., Sayyed, A. A., Jain, M., Ali, S. A., Gondaliya, P., Kalia, K., & Tekade, R. K. (2022) · Biomaterials Science · doi:10.1039/d2bm00951j · Cited by 17
Engineering perfused microvascular networks into microphysiological systems platforms
Andrejecsk, J. W., & Hughes, C. C. W. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.02.002 · Cited by 18
Self-citationFibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease
Streutker, E. M., Devamoglu, U., Vonk, M. C., Verdurmen, W. P. R., & Gac, S. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303991 · Cited by 18
Vascular microphysiological systems (MPS): biologically relevant and potent models
Breuil, L., Kitada, A., Yadav, S., Zhou, H., Fujimoto, K., & Yokokawa, R. (2025) · Lab on a Chip · doi:10.1039/d5lc00014a · Cited by 19
Kim, H., Cho, S., & Kim, H. N. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500240 · Cited by 18
“Compared to immortalized cell lines, patient-derived tumor organoids or primary tumor spheroids preserve interpatient heterogeneity and have demonstrated differential responses to antiangiogenic or cytotoxic agents in vas-8 cularized microfluidic environments [34, 41, 49, 50, 107, 108].”
Poljak, I., Chiappini, C., & Adriani, G. (2026) · Lab on a Chip · doi:10.1039/d5lc01060h · Cited by 17
Extracellular Matrix Remodeling in Intestinal Homeostasis and Disease
Lee, S.-E., Massie, I., Meran, L., & Li, V. S. W. (2018) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2018.01.001 · Cited by 16
Understanding organotropism in cancer metastasis using microphysiological systems
Ko, J., Song, J., Lee, Y., Choi, N., & Kim, H. N. (2024) · Lab on a Chip · doi:10.1039/d3lc00889d · Cited by 15
Lee, G., Kim, S. J., & Park, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303716 · Cited by 16
Zhang, F., Jozani, K. A., Chakravarty, A., Lin, D. S. Y., Hollinger, A., Rajasekar, S., & Zhang, B. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202402946 · Cited by 16
Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
Kim, J., Jang, J., & Cho, D. (2021) · Micromachines · doi:10.3390/mi12091122 · Cited by 13
“established the “tumor-on-a-chip” microfluidics platform that could grow cancer cells and endothelial cells to form vascularized microtumors [61].”
BackgroundBaka, Z., Stiefel, M., Figarol, A., Godier, C., Mallick, A., Joubert, O., Ashammakhi, N. A., Gaffet, É., & Alem, H. (2022) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ac8259 · Cited by 15
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Self-citationFlow‐Induced Vascular Remodeling on‐Chip: Implications for Anti‐VEGF Therapy
Mirzapourshafiyi, F., Huber, E., Karr, L., Tong, J., Bausch, A. R., Simmel, F. C., & Alim, K. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202501416 · Cited by 16
“Increasing the number of openings from the typical range of 3-10 used in previous studies [32], [38] to 24 openings significantly reduced the statistical risk of poor connectivity.”
InfluentialMicrophysiological systems to study tumor-stroma interactions in brain cancer
Neves, E. R., Harley, B. A. C., & Pedrón, S. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.012 · Cited by 14
Realizations of vascularized tissues: From in vitro platforms to in vivo grafts
Ren, B., Jiang, Z., Murfee, W. L., Katz, A. J., Siemann, D. W., & Huang, Y. H. (2023) · Biophysics Reviews · doi:10.1063/5.0131972 · Cited by 13
Wang, D., Li, Q., Zhou, C., Li, Z., Lu, K., Liu, Y., Xuan, L., & Wang, X. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-023-00267-x · Cited by 14
Self-citationAdaptable Manufacturing and Biofabrication of Milliscale Organ Chips With Perfusable Vascular Beds
Byrne, C. E., Martier, A. T., Kpeli, G. W., Conrad, K. M., Bralower, W., Olsen, E., Fortes, G., Culp, C. C., Wendell, M., Boone, K. A., et al. (2024) · Biotechnology Journal · doi:10.1002/biot.202400550 · Cited by 12
Joint registration of multiple point clouds for fast particle fusion in localization microscopy
Wang, W., Heydarian, H., Huijben, T. A. P. M., Stallinga, S., & Rieger, B. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac320 · Cited by 12
Esparza, A., Jimenez, N., Borrego, E. A., Browne, S., & Natividad-Diaz, S. L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09048-2 · Cited by 16
“2) [25, 27, 40–44, 46, 48–52].”
Targeted Cancer Therapy‐on‐A‐Chip
Abed, H., Radha, R., Anjum, S., Paul, V., AlSawaftah, N., Pitt, W. G., Ashammakhi, N. A., & Husseini, G. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400833 · Cited by 13
The promise of Synovial Joint-on-a-Chip in rheumatoid arthritis
Zhang, X., Su, R., Wang, H., Wu, R., Fan, Y., Bin, Z., Gao, C., & Wang, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1408501 · Cited by 13
The Role of Organoids in Advancing Colorectal Cancer Research: Insights and Future Directions
Heydari, Z., Balaya, R. D. A., Sarkar, G., & Boardman, L. (2025) · Cancers · doi:10.3390/cancers17132129 · Cited by 14
“These advancements will be crucial for translating composite organoid models into robust platforms for studying CRC biology and guiding immunotherapy development.”
Voeltzel, T., Fossard, G., Degaud, M., Geistlich, K., Gadot, N., Jeanpierre, S., Mikaélian, I., Brevet, M., Anginot, A., Bousse‐Kerdilès, M. L., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm01098k · Cited by 13
Capturing membrane trafficking events during 3D angiogenic development in vitro
Francis, C. R., & Kushner, E. J. (2021) · Microcirculation · doi:10.1111/micc.12726 · Cited by 9
“could be very interesting for investigating trafficking patterns with flow [27].”
BackgroundKim, S. J., Lee, G., & Park, J. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202101326 · Cited by 12
Discovery and Development of Tumor Angiogenesis Assays
Natale, G., & Bocci, G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2703-7_1 · Cited by 14
Integrating Hierarchical Vasculature into Engineered Cardiac Tissues
Zhuang, R. Z., Chesnais, F., & Vunjak‐Novakovic, G. (2025) · Advanced Materials · doi:10.1002/adma.202509242 · Cited by 11
Kashkooli, F. M., Mirala, F., Tehrani, M. H. H., Alirahimi, M., Souri, M., Golzaryan, A., Kar, S., & Soltani, M. (2025) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.70000 · Cited by 19
Patient-Derived In Vitro and In Vivo Models of Cancer
Claridge, S. E., Cavallo, J., & Hopkins, B. D. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_12 · Cited by 11
A Review of Functional Analysis of Endothelial Cells in Flow Chambers
Ohta, M., Sakamoto, N., Funamoto, K., Wang, Z., Kojima, Y., & Anzai, H. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13030092 · Cited by 11
Pyo, D. H., Hong, H. K., Lee, W. Y., & Cho, Y. B. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1738907 · Cited by 13
“induced chemotaxis of human umbilical vein endothelial cells (HUVECs).(72) Despite recent rapid progress in the organ-”
BackgroundApplication of microfluidic technology in cancer research and therapy
Azadi, S., Es, H. A., Kulasinghe, A., Bordhan, P., & Warkiani, M. E. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.02.012 · Cited by 12
Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism
Chen, J., Lee, H., Schmitt, P., Choy, C. K., Miller, D. M., Williams, B. J., Bearer, E. L., & Frieboes, H. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab092 · Cited by 10
Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research
Hachey, S. J., Gaebler, D., & Hughes, C. C. W. (2023) · Journal of Visualized Experiments · doi:10.3791/65865 · Cited by 12
Self-citationGhosh, A. K., Ghosh, S., Pati, F., & Duraiswamy, S. (2023) · Bioprinting · doi:10.1016/j.bprint.2023.e00316 · Cited by 9
Microfluidic channel with embedded monolayer nanofibers for cell culture and co-culture
Huang, B., He, Y., Wang, L., Shi, J., Hu, J., Rofaani, E., Yamada, A., & Chen, Y. (2020) · Microelectronic Engineering · doi:10.1016/j.mee.2020.111235 · Cited by 13
Advancing Tumor Microenvironment Research by Combining Organs-on-Chips and Biosensors
Calejo, I., Heinrich, M. A., Zambito, G., Mezzanotte, L., Prakash, J., & Teixeira, L. M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_7 · Cited by 9
Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks
Swaminathan, S., & Clyne, A. M. (2020) · Journal of Visualized Experiments · doi:10.3791/61791 · Cited by 9
Parihar, P., Sunildutt, N., Rahim, C. S. A., Samantasinghar, A., Lim, J., & Choi, K. H. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300410 · Cited by 10
Cellular Systems for Colorectal Stem Cancer Cell Research
Grigoreva, T. A., Kindt, D. N., Sagaidak, A. V., Novikova, D., & Tribulovich, V. G. (2025) · Cells · doi:10.3390/cells14030170 · Cited by 8
Murillo, L. L., Green, M., Mahon, N., Saiani, A., & Tsigkou, O. (2025) · Cancers · doi:10.3390/cancers17101675 · Cited by 10
“So-brino et al. [190] developed micro-tumours in the presence of a microfluidic platform lined with endothelial colony-forming cell-derived ECs (ECFC-ECs) isolated from cord blood.”
Hatch, C. J., Piombo, S. D., Fang, J. S., Gach, J. S., Ewald, M. L., Trigt, W. K. V., Coon, B. G., Tong, J. M., Forthal, D. N., & Hughes, C. C. W. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1360364 · Cited by 8
Self-citationDesign principles for dynamic microphysiological systems
Cooper, M. H., Charest, J. L., & Coppeta, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00001-3 · Cited by 11
On-Demand Radial Electrodeposition of Alginate Tubular Structures
Kingsley, D. M., Capuano, J. A., & Corr, D. T. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00415 · Cited by 9
Egloff‐Juras, C., Yakavets, I., Scherrer, V., François, A., Bezdetnaya, L., Lassalle, H., & Dolivet, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041966 · Cited by 12
Highlight: microfluidic devices for cancer metastasis studies
Scemama, A., Lunetto, S., & Biddle, A. (2022) · In vitro models · doi:10.1007/s44164-022-00023-y · Cited by 8
“It was shown that drugs targeting multiple vascular receptors promoted vascular regression, as opposed to molecules targeting vascular endothelial growth factor receptors only [36].”
BackgroundTranslational strategy: humanized mini-organs
Nguyen, D. T., Althage, M., Magnone, M. C., & Heydarkhan‐Hagvall, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.039 · Cited by 8
Microfluidic Conjugating AI Platform for High‐throughput Nanomedicine Screening
Huang, X., Liao, W., Xu, Z., & Song, Y. (2024) · Wiley eBooks · doi:10.1002/9783527830404.ch17 · Cited by 8
Kowalski, W. J., Vatti, S., Sakamoto, T., Li, W., Odutola, S. R., Liu, C., Chen, G., Boehm, M., & Mukouyama, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-91826-y · Cited by 13
“Microchannel networks take advantage of instrumentation and imaging access to investigate microvascular remodeling and disease 31–33 .”
Advances and Applications of Organ-on-a-Chip and Tissue-on-a-Chip Technology
Moore, M., Sriram, S., Ku, J. C., & Li, Y. (2025) · Bioengineering · doi:10.3390/bioengineering13010009 · Cited by 10
“OoCs allow for the use of vascularized micro-tumors by co-culturing with additional cell types such as adipocytes, fibroblasts, and leukocytes, allowing for greater replicability of cell–cell communication and extracellular matrix conditions found in vivo [69–71].”
Fukushi, M., Kinoshita, K., Yamada, M., Yajima, Y., Utoh, R., & Seki, M. (2019) · RSC Advances · doi:10.1039/c9ra00257j · Cited by 6
Jeong, C. G., Negro, G. D., Getsios, S., & Ekert, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00005-0 · Cited by 13
Rojek, K. O., Wrzos, A., Żukowski, S., Bogdan, M. J., Lisicki, M., Szymczak, P., & Guzowski, J. (2024) · APL Bioengineering · doi:10.1063/5.0180703 · Cited by 6
Patient-derived melanoma models
Karras, F., & Kunz, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155231 · Cited by 6
Breast Organotypic Cancer Models
Carranza‐Rosales, P., Guzmán‐Delgado, N. E., Torres, I. E. C., Viveros‐Valdez, E., & Morán‐Martínez, J. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_86 · Cited by 7
Metadata
- Authors
- Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31589-31589
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994029
- OpenAlex
- W2510834891
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 23 · 2025: 34 · 2024: 41 · 2023: 36 · 2022: 52 · 2021: 56 · 2020: 52 · 2019: 29 · 2018: 35 · 2017: 28 · 2016: 1
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Coordinating Council for Women in History
- National Institutes of Health (UH3TR000481, UL1TR001414, UH2TR000481)
- National Cancer Institute (R01CA170879, P30A062203, R01CA180122)
- National Center for Advancing Translational Sciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-on-a-chip, 3D extracellular matrix, colorectal cancer, breast cancer, tumor stroma, vascular targeting agents, VEGFR inhibitors, PDGFR inhibitors, metabolic heterogeneity, aerobic glycolysis, drug response
- MeSH terms
- Breast Neoplasms, Female, Humans, Male, Models, Biological, Neovascularization, Pathologic, Colorectal Neoplasms, Angiogenesis Inhibitors, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.